Shoulder Innovations Secures $2.5M Series A Funding to Accelerate Development of Its InSet Shoulder Arthroplasty Platform

Recently, VCBeat (WeChat Official Account: vcbeat) learned from foreign media reports that Shoulder Innovations, a Michigan-based leader in the development of shoulder replacement systems, has completed a $2.5 million Series A financing round. The round was led by Michigan Angel Fund, with participation from Wakestream Ventures, Genesis Innovation Group, cultivate(MD), and other equity holders.

Shoulder Innovations, founded in 2015, is a medical device development company dedicated to designing innovative commercial products that enhance patient care experiences and reduce the overall costs of healthcare systems. The company primarily focuses on the research and development of shoulder arthroplasty systems, having developed an integrated glenoid fixation technology that has created the strongest and most stable glenoid platform in the industry. This technology addresses the primary cause of revision shoulder surgeries by resolving the critical issue of “glenoid implant loosening” in shoulder arthroplasty, thereby ensuring exceptional implant stability.

This technology platform is positioned in the market to offer direct and convenient surgical techniques, highly stable implants, and streamlined instruments. The company intends to leverage this technology to manufacture simple surgical instruments, thereby reducing surgical time and costs while improving surgical performance. Currently, Shoulder Innovations is commercializing its shoulder joint replacement implant system based on its patented embedded glenoid design.

Kip Simms, Managing Director of the Michigan Angel Fund, stated: “The Shoulder Innovations team has developed truly cutting-edge and disruptive products in the field of orthopedics in an efficient manner, which we are pleased to see as investors.”

Upon completion of this round of financing, Shoulder Innovations plans to utilize the funds for new product development, expand its product inventory and asset base, and accelerate the growth of its existing Inset platform technology.

“Over the past few quarters, Shoulder Innovations has achieved remarkable progress in both commercial growth and innovative development. We will continue this work, which has a significant impact on the lives of many people. Fortunately, our investment partners are also supporting and encouraging these efforts,” said Rob Ball, Executive Chairman of Shoulder Innovations.

Currently, more than 100,000 patients worldwide undergo shoulder replacement surgery, with demand growing by 10% annually. The global shoulder arthroplasty market is valued at over $1 billion and is projected to double by 2023.

Michigan Angel Fund specializes in angel-stage investments, primarily targeting early-stage startups in the IT, clean technology, advanced manufacturing, and healthcare sectors that are either profitable or nearing profitability. Investment amounts range from $200,000 to $2 million. The fund prefers companies seeking less than $2 million in funding to achieve break-even or sustainable growth.

Wakestream Ventures is an early-stage venture capital fund with a rich investment history in the fields of innovation, industrial design, and manufacturing. The fund’s initial investments range from $100,000 to $300,000, with cumulative follow-on commitments in Series B and C rounds reaching up to $1.5 million.

Genesis Innovation Group is a technology-driven company focused on the orthopedics sector, driving value creation by identifying and addressing unmet needs in the orthopedic market. Additionally, as an R&D consulting firm, its strategy typically involves deep engagement and self-funding to align partners toward shared objectives, fostering an ideal win-win relationship.

Cultivate (MD), based in Michigan, USA, is a medical venture capital firm that primarily invests in the research and development of medical devices.